Results 61 to 70 of about 134,517 (163)

Esthesioneuroblastomas: Reservations and Recommendations [PDF]

Journal of Clinical and Diagnostic Research, 2016
Neuroectodermal tumour has a wide range of biological activity that ranges from an indolent course to local recurrence and rapid widespread metastasis. We describe, herewith, 2 patients with Esthesioneuroblastomas (ENB) who had varied atypical clinical
Rajesh Nair, Bhavna Nayal, Vinod Kumar, Padmapriya Jaiprakash   +3 more
doaj   +1 more source

Frontal Sinus “Hump”: An Anatomical Risk Factor for Anterior Skull Base Injury in the Endoscopic Modified Lothrop Approach (Outside-In Frontal Drill-Out)

Case Reports in Otolaryngology, 2021
Skull base injuries caused by the outside-in frontal drill-out technique have not been reported. In this report, we chose an outside-in approach to open the frontal sinus for olfactory neuroblastoma resection.
Teppei Takeda, Kazuhiro Omura, Haw Torng, Teru Ebihara, Satoshi Aoki, Kosuke Tochigi, Hiromi Kojima, Nobuyoshi Otori   +7 more
doaj   +1 more source

DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management

International Journal of Cancer, Volume 159, Issue 11, Page 2736-2754, 1 December 2026.
ABSTRACT Wilms Tumour (WT), the most common kidney cancer in children, presents features of altered kidney development and frequently exhibits molecular alterations at the 11p15.5 imprinted locus, affecting the IGF2 and H19 genes, which contribute to tumour growth and predisposition.
Abu Saadat, Francesco Cecere, Federica Rossetti, Laura Pignata, Emilia D'Angelo, Carlo Giaccari, Gaetano Verde, Paola Quarello, Franca Fagioli, Josep Roma, Manel Esteller, Enrique de Álava, Flavia Cerrato, Andrea Riccio, Angela Sparago   +14 more
wiley   +1 more source

Supplementary Data from Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications

, 2017
Figure S1. (A) Overexpression of p53 in olfactory neuroblastoma tumor harboring an inactivating TP53 mutation. (B) Representative example of p53 expression in olfactory neuroblastoma tumor lacking TP53 mutation.
Jonathan B. McHugh (9582084), Lorena Lazo de la Vega (15007548), Paul W. Harms (14925723), Dan Robinson (228751), Komal Kunder (15077037), Chia-Jen Liu (328474), Frances M. Walocko (15077040), Arul M. Chinnaiyan (59535), Daniel H. Hovelson (14919882), Andi K. Cani (14919885), Scott A. Tomlins (14875139)   +10 more
core   +1 more source

Olfactory neuroblastoma

Chinese Journal of Contemporary Neurology and Neurosurgery, 2017
DOI: 10.3969/j.issn.1672-6731.2017.05 ...
Tong HAN
doaj  

The genomics and epigenetics of olfactory neuroblastoma: A systematic review

Laryngoscope Investigative Otolaryngology, 2021
Background Olfactory neuroblastoma (ONB) or esthesioneuroblastoma (ENB) is a rare malignancy of the nasal cavity believed to arise from the olfactory epithelium.
Raman Preet Kaur, Evgeny Izumchenko, Dukagjin M. Blakaj, Nikol Mladkova, Matt Lechner, Thomas L. Beaumont, Charalampos S. Floudas, Gary L. Gallia, Nyall R. London Jr   +8 more
doaj   +1 more source

Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study

Head &Neck, Volume 48, Issue 10, Page 2704-2712, October 2026.
ABSTRACT Background Sinonasal malignancies (SNM) are rare, heterogeneous tumors with poor prognosis. There is an unmet need to improve treatment outcomes. Despite advances in imaging and molecular classification, optimal curative radiotherapy (RT) strategies remain undefined.
M. de Ridder, L. J. van de Velde, T. de Bie, R. van Noortwijk, C. P. J. Raaijmakers, E. H. Voormolen, W. W. Braunius, R. de Bree, G. E. Breimer, L. A. Devriese, E. J. Smid, J. A. Rijken   +11 more
wiley   +1 more source

Neuroblastoma olfatorio. Todo lo que el radiólogo debe saber [PDF]

, 2020
Olfactory neuroblastoma (ONB) is a rare malignant tumor that originates from olfactory neuroepithelial cells. Its early diagnosis is difficult due to the low specificity of the symptoms.
Gimeno Peribáñez, M.J., Gasos Lafuente, A., Moreno Caballero, L., Navas-Campo, R., Séez Valero, E., Tobajas Morlana, P., Raquel Navas-Campo, Eduardo Séez Valero, Ana Gasos Lafuente, María José Gimeno Peribáñez, Leticia Moreno Caballero, Pilar Tobajas Morlana   +11 more
core   +1 more source

The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study

Health Science Reports, 2021
Background In this retrospective surveillance, epidemiology, and end results (SEER) registry analysis, we investigated the role of chemotherapy (CT) in the treatment of olfactory neuroblastoma (ON), an exceedingly rare sino‐nasal tumor typically treated ...
Ryan J. Brisson, Thomas J. Quinn, Rohan L. Deraniyagala   +2 more
doaj   +1 more source

Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study

Head &Neck, Volume 48, Issue 10, Page 2810-2820, October 2026.
ABSTRACT Introduction Sinonasal cancers are rare and heterogeneous and pose a therapeutic challenge at an advanced stage due to the lack of data on appropriate systemic management. Methods This retrospective multicenter study analyzed 83 patients with recurrent or metastatic sinonasal carcinomas ineligible for curative treatment, treated in France ...
Marie Degrange, Mathilde Morisseau, Justin Michel, Thibaut Reverdy, Sylvain Morinière, Amaury Daste, Maxime Humbert, Caroline Viala, Pauline Corbaux, Tiffany Darbas, François‐Régis Ferrand, Valentin Favier, Camille Evrard, Diane Evrard, Delphine Farneti, Sarah Betrian‐Lagarde, Victor Sarradin   +16 more
wiley   +1 more source